Aceclofenac (Vitafen®)

Assessment Status Rapid Review Complete
Drug Aceclofenac
Brand Vitafen®
Indication For the relief of pain and inflammation in osteoarthritis, rheumatoid arthritis and ankylosing spondylitis.
Assessment Process
Rapid review commissioned 24/08/2016
Rapid review completed 24/01/2017
Rapid review outcome Following a resubmission of the rapid review a full pharmacoeconomic evaluation is recommended at the submitted price.

The HSE has approved reimbursement following confidential price negotiations  Nov 2017.